Related Experiment Video
Updated: Aug 8, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
[Multidrug resistance]
1Urologische Klinik, Klinikum Dijkzigt, Erasmus Universität Rotterdam.
Abstract:
The past decade has seen the successful application of genetic techniques in the dissection of the most important phenotypes of cancer cells. In the case of drug resistance mechanisms, the elucidation of the genes involved in resistance to anticancer agents has led to new and unexpected information about tumor physiology and may well open therapeutic options by virtue of reversing clinical chemoresistance. The experimental characterization of defined multidrug resistance factors, such as P-glycoprotein, multidrug resistance associated protein, topoisomerase, or glutathione-S-transferase in urologic malignancies, is now relatively comprehensive, allowing for an initial analysis. Clinical studies on some of these concepts have been started and will be the subject of careful scrutiny. We expect that they will have a considerable impact on the way certain urologic anticancer strategies will be pursued in the future.
Insights
Genetic techniques have illuminated cancer cell drug resistance mechanisms, revealing insights into tumor physiology and potential strategies to reverse chemoresistance in urologic malignancies.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Genetic techniques have advanced the understanding of cancer cell phenotypes over the past decade.
- Elucidating drug resistance mechanisms offers new insights into tumor physiology.
Purpose of the Study:
- To analyze the role of defined multidrug resistance factors in urologic malignancies.
- To explore therapeutic options for reversing clinical chemoresistance.
Main Methods:
- Experimental characterization of specific multidrug resistance factors.
- Analysis of genes involved in resistance to anticancer agents.
- Initiation of clinical studies based on these findings.
Main Results:
- Comprehensive characterization of key multidrug resistance factors (e.g., P-glycoprotein, topoisomerase) in urologic cancers.
- Identification of novel information regarding tumor physiology related to drug resistance.
Conclusions:
- Understanding drug resistance mechanisms can lead to new therapeutic strategies.
- These findings are expected to significantly impact future urologic anticancer treatment strategies.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Mismatch Repair
Antibiotic Selection
Treatment Resistant Cancers
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance